UBS highlights Bio-Rad Labs' (BIO) margin expansion opportunity, reiterates Buy rating
Tweet Send to a Friend
UBS analyst Dan Leonard reiterated a Buy rating and $325.00 price target on Bio-Rad Labs (NYSE: BIO).The analyst commented, "Our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
